The value of regional lymph node dissection in genitourinary cancer
- 1 January 1989
- journal article
- research article
- Published by Wiley in Seminars in Surgical Oncology
- Vol. 5 (4) , 235-239
- https://doi.org/10.1002/ssu.2980050405
Abstract
Regional lymph node dissection in the management of genitourinary (GU) neoplasms is controversial but is based on a 17 year clinical experience and the achievement of survival figures as good or better than those achieved by any other modality of therapy. Lymphadenectomy has proved to be effective in curing patients with metastatic testicular cancer, renal cell carcinoma and transitional cell carcinoma. Its efficacy in prostate cancer is much less certain and remains largely a staging procedure.Keywords
This publication has 13 references indexed in Scilit:
- Radical Surgery Versus Radiotherapy for Adenocarcinoma of the ProstateJournal of Urology, 1982
- Regional Lymph Node Metastasis From Bladder CancerJournal of Urology, 1981
- Pelvic Lymphadenectomy in the Management of Carcinoma of the ProstateJournal of Urology, 1980
- The Role of Lymphadenectomy in the Management of Renal Cell CarcinomaUrologic Clinics of North America, 1980
- Preoperative irradiation and cystectomy in 135 cases of bladder cancerUrology, 1976
- Radical Thoracoabdominal Nephrectomy for Renal Cell CarcinomaJournal of Urology, 1973
- The Upper Limits of Hopeful Application of Radical Cystectomy for Vesical Carcinoma: Does Nodal Metastasis Always Indicate Incurability?Journal of Urology, 1973
- Extension of Renal Cell Carcinoma into the Vena Cava: The Rationale for Aggressive Surgical ManagementJournal of Urology, 1972
- Diagnosis and management of renal cell carcinomaA clinical and pathologic study of 309 casesCancer, 1971
- The Results of Radical Nephrectomy for Renal Cell CarcinomaJournal of Urology, 1969